[KongchangAI]
Unverified88% confidenceCautionTime unknown

追求最低用药成本的患者不太适合坚持选用辉瑞原研药,尤其在国家集采政策下,通过一致性评价的仿制药已大幅降价

1
Sources
88%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/811868
API
curl https://kongchang.com/api/v1/knowledge/claims/811868
MCP
get_claim(id=811868)